Less than a year after getting into hot water with the U.S. Food & Drug Administration, Bristol-Myers Squibb in Manatí has reportedly solved its problems and is back in the regulator’s good graces.
A little over a year after acquiring a plant formerly owned by Biovail in Dorado, Blu Caribe announced Wednesday a $2.5 million upgrade to its plant that will create 115 new jobs and allow the addition of more products to its manufacturing line in coming months.
The once manufacturing-centric town of Cidra will see another of its industrial tenants shutting down in August, as a result of Wednesday’s announcement by Ciba Vision that it will cease production of its Specialty Soft line of contact lenses there.
The head of the U.S House of Representatives Oversight Committee, Rep. Darrell Issa (R-Calif.), recently blasted the U.S. Food & Drug Administration for failing to properly monitor Johnson & Johnson’s McNeil unit in Las Piedras, which last year got into trouble for production flaws that led to massive recalls.
esearch firm Business Monitor International on Monday predicted that Puerto Rico's pharmaceutical industry will show a slight growth of 2.5 percent next year, despite the looming threat of the effects of Law 154, which starting in January levies a 4 percent excise tax on foreign corporations doing business on the island.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA